Role of steroid priming in the treatment of chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue SUPPL. MAY, 2000, Pages

  Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; STEROID;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD;

EID: 0033919379     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02109.x     Document Type: Conference Paper

References (25)

1. Weller IVD, Bassendine MF, Murray AK, Craxo A, Thomas HC, Sherlock S. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut 1982; 23: 650-5.
2. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosupressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81: 987-91.
3. Muller R, Vido I, Schmidt FW Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection. Lancet 1981; 1: 1323-4.
4. Rakela J, Redeker AG, Weliky B. Effect of short-term prednisolone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983; 84: 956-60.
5. Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatobgy 1986; 6: 1319-24.
6. Hoofnagle JH, Davis GL, Pappas SC et al. A short course of prednisolone in chronic type B hepatitis. Ann. Intern. Med. 1986; 104: 12-17.
7. Sjogren MH, Hoofnagle JH, Waggoner JG. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Hepatology 1987; 7: 582-5.
8. Lee S-D, Tong MJ, Wu J-C, Lin H-C, Tsai Y-T, Lo K-J. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. J. Hepatol. 1991; 12: 246-50.
9. Omata M, Imazeki F, Yokosuka O et al. Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Gastroenterology 1985; 88: 870-80.
10. Yokosuka O, Omata M, Imazeki F et al. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B: a controlled study. Gastroenterology 1985; 89: 246-51.
11. Brissot P, Jacquelinet C, Jouanolle H et al. Short-term prednisolone followed by recombinant human alfa-interferon alone or combined with adenine-arabinoside in chronic hepatitis B: A prospective and randomized trial. J. Hepatol. 1991; 12: 181-9.
12. Perrillo RP, Regenstein FG, Peters MG et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis: A randomized, controlled trial. Ann. Int. Med. 1988; 109: 95-100.
13. Perrillo RP, Schiff ER, Davis GL et al. and the Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N. Engl. J. Med. 1990; 323: 295-301.
14. Fevery J, Elewaut A, Michielsen P et al. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B: A prospective double-blind Belgian-Dutch study. J. Hepatol. 1990; 11: S108-12.
15. Perez V, Tanno H, Villamil F, Fay O. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis. J. Hepatol. 1990; 11: S113-17.
16. Niederau C, Heintges T, Niederau M, Stremmel W, Strohmeyer G. Prospective randomized controlled trial of sequential treatment with corticoids and alfa-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. Eur. J. Med. 1992; 1: 396-402.
17. Reichen J, Bianchi L, Frei PC et al. and the Swiss Association for the Study of the Liver. Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. J. Hepatol. 1994; 20: 168-74.
18. Lok ASF, Wu P-C, Lai C-L et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 2091-7.
19. Liaw Y-F, Lin S-M, Chen T-J, Chien R-N, Sheen I-S, Chu C-M. Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. J. Hepatol. 1994; 20: 175-80.
20. Cohard M, Poynard T, Mathurin P, Zarski JP. Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect meta-analysis. Hepatology 1994; 20: 1390-8.
21. Gregorio GV, Jara P, Hierro L et al. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology 1996; 23: 700-7.
22. Krosgaard K, Marcellin P, Trepo C et al., Bindslev N (statistician) and other members of Interpred Trial Group. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. J. Hepatol. 1996; 25: 803-13.
23. Omata M, Uchiumi K. Combination of prednisolone withdrawal and anti-viral agents (adenine arbinoside, interferon) in chronic hepatitis B. J. Hepatol. 3: S65-9.
24. Perez V, Findor J, Tanno H, Sorda J. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long-term follow-up. Gut 1993; (Suppl.): S91-4.
25. Lin S-M, Sheen I-S, Chien R-N, Chu C-M, Liaw Y-F. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999; 29: 971-5.